Results 191 to 200 of about 9,032 (208)

Graves’ Ophthalmopathy

2016
Claudio Marcocci, Terry J. Smith
openaire   +1 more source

Increased Generation of Fibrocytes in Thyroid-Associated Ophthalmopathy

Journal of Clinical Endocrinology and Metabolism, 2010
Kelvin Chong, Terry J Smith
exaly  

Insights Into Local Orbital Immunity: Evidence for the Involvement of the Th17 Cell Pathway in Thyroid-Associated Ophthalmopathy

Journal of Clinical Endocrinology and Metabolism, 2019
Sijie Fang, Ningjian Wang, Bin Li
exaly  

Immunological Aspects of Graves’ Ophthalmopathy

BioMed Research International, 2019
Alicja Głuszko, Grażyna Nowicka, Miroslaw Jerzy Szczepanski   +2 more
exaly  

Thyroid-Associated Ophthalmopathy after Treatment for Graves’ Hyperthyroidism with Antithyroid Drugs or Iodine-131

Journal of Clinical Endocrinology and Metabolism, 2009
Jan Calissendorff, Mikael Lantz
exaly  

Graves' Ophthalmopathy

New England Journal of Medicine, 2011
openaire   +1 more source

Treatment Modalities for Graves’ Ophthalmopathy: Systematic Review and Metaanalysis

Journal of Clinical Endocrinology and Metabolism, 2009
Hadas Stiebel-Kalish, Eyal Robenshtok, Murat Hasanreisoglu   +2 more
exaly  

Rituximab Treatment of Patients with Severe, Corticosteroid-Resistant Thyroid-Associated Ophthalmopathy

Ophthalmology, 2010
Dinesh Khanna, Terry J Smith
exaly  

Graves' Ophthalmopathy

Archives of Ophthalmology, 1985
openaire   +1 more source

Thyrotropin Receptor Autoantibodies Are Independent Risk Factors for Graves’ Ophthalmopathy and Help to Predict Severity and Outcome of the Disease

Journal of Clinical Endocrinology and Metabolism, 2006
exaly